Physician profile
Mark D Abel
NPI 1871649780
$1,663.71
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,091 · 2021: $146 · 2022: $56.43 · 2023: $251 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253 · Education: $100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.84 |
| Education | $100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3shape INC | $1,000.00 | 2019 | |
| Dentsply Sirona INC | $323.24 | 2021-2023 | Astra Tech Implant System |
| Zimvie INC. | $155.95 | 2023-2024 | |
| Straumann USA LLC | $150.19 | 2019-2024 | |
| Keystone Dental INC. | $18.80 | 2019 | |
| Geistlich Pharma, North America, INC. | $15.53 | 2024 | Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.